Fosaprepitant Injection and Insulin glargine and lixisenatide
Determining the interaction of Fosaprepitant Injection and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: Fosaprepitant
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fosaprepitant Injection-Insulin glargine and lixisenatide Subcutaneous
- Fosaprepitant Injection-Insulin glargine, recombinant Subcutaneous
- Fosaprepitant Injection-Insulin glulisine
- Fosaprepitant Injection-Insulin Glulisine (Cartridges and Pens)
- Fosaprepitant Injection-Insulin Glulisine (Vials)
- Fosaprepitant Injection-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Fosaprepitant Intravenous
- Insulin glargine and lixisenatide-Foscarnet
- Insulin glargine and lixisenatide-Foscarnet Intravenous
- Insulin glargine and lixisenatide-Foscarnet Sodium
- Insulin glargine and lixisenatide-Foscavir
- Insulin glargine and lixisenatide-Fosfomycin